UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SPCX
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.94% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OBE
5276
Obsidian Energy
OBE
$818M
| $1.59M | ﹤0.01% |
196,061
-377,855
| -66% | -$4.24M |
|
5277
Fate Therapeutics
FATE
$303M
| $1.59M | ﹤0.01% |
590,178
-1,231,537
| -68% | -$2.28M |
|
5278
State Street SPDR S&P Emerging Asia Pacific ETF
GMF
$432M
| $1.59M | ﹤0.01% |
10,132
-51
| -0.5% | -$7.71K |
|
5279
Invesco Dorsey Wright Industrials Momentum ETF
PRN
$365M
| $1.59M | ﹤0.01% |
6,093
-1,485
| -20% | -$349K |
|
5280
Regional Management Corp
RM
$290M
| $1.59M | ﹤0.01% |
38,484
+3,611
| +10% | +$132K |
|
5281
CALL
ENI
E
$78.4B
| $1.58M | ﹤0.01% |
+33,800
| New | +$1.81M |
|
5282
Covenant Logistics
CVLG
$858M
| $1.58M | ﹤0.01% |
35,846
-3,583
| -9% | -$131K |
|
|
SOFX
5283
Defiance Daily Target 2X Long SOFI ETF
SOFX
$53.8M
| $1.58M | ﹤0.01% |
153,467
-25,630
| -14% | -$254K |
|
|
GDXY
5284
YieldMax Gold Miners Option Income Strategy ETF
GDXY
$319M
| $1.58M | ﹤0.01% |
156,060
+10,386
| +7% | +$130K |
|
5285
STRATTEC Security
STRT
$269M
| $1.58M | ﹤0.01% |
19,351
+4,333
| +29% | +$330K |
|
5286
PUT
Nutrien
NTR
$36.8B
| $1.57M | ﹤0.01% |
25,000
| – | – |
|
5287
Microbot Medical
MBOT
$91.3M
| $1.57M | ﹤0.01% |
806,847
-10,098
| -1% | -$20.6K |
|
5288
iShares ESG Advanced Universal USD Bond ETF
EUSB
$705M
| $1.57M | ﹤0.01% |
36,187
+5,137
| +17% | +$223K |
|
5289
PUT
AbCellera Biologics
ABCL
$4.09B
| $1.57M | ﹤0.01% |
+200,000
| New | +$978K |
|
|
BWAY
5290
Brainsway
BWAY
$548M
| $1.57M | ﹤0.01% |
101,077
+18,935
| +23% | +$287K |
|
5291
Akebia Therapeutics
AKBA
$254M
| $1.57M | ﹤0.01% |
1,374,950
+605,479
| +79% | +$721K |
|
5292
Zura Bio
ZURA
$427M
| $1.57M | ﹤0.01% |
265,314
+24,287
| +10% | +$116K |
|
5293
Hamilton Insurance Group
HG
$3.45B
| $1.57M | ﹤0.01% |
46,116
-117,433
| -72% | -$3.68M |
|
5294
ARK Israel Innovative Technology ETF
IZRL
$134M
| $1.56M | ﹤0.01% |
51,500
+5,053
| +11% | +$152K |
|
5295
CALL
Qiagen
QGEN
$8.95B
| $1.56M | ﹤0.01% |
40,000
-8,900
| -18% | -$331K |
|
|
BTQ
5296
BTQ Technologies Corp
BTQ
$384M
| $1.56M | ﹤0.01% |
289,999
-98,215
| -25% | -$367K |
|
5297
Compass Therapeutics
CMPX
$342M
| $1.56M | ﹤0.01% |
712,763
-1,678,570
| -70% | -$4.96M |
|
5298
RBB Bancorp
RBB
$452M
| $1.56M | ﹤0.01% |
56,794
+44,319
| +355% | +$1.06M |
|
|
TLX
5299
Telix Pharmaceuticals
TLX
$4.28B
| $1.55M | ﹤0.01% |
134,698
+102,398
| +317% | +$1.04M |
|
|
RMMZ
5300
RiverNorth Managed Duration Municipal Income Fund II
RMMZ
$117M
| $1.55M | ﹤0.01% |
103,111
-1,228
| -1% | -$18.2K |
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,279 new, 4,220 increased, 4,368 reduced and 1,272 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,279 new positions and closed 1,272 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.